AnalystsGavin Clark-GartnerGavin Clark-Gartner's Stock Forecasts
AnalystsGavin Clark-Gartner
Analyst Ranking
Bottom 15%
#4737 out of 5558 analysts
Average Return
-0.46%
Win Rate
48%29 out of 61
Risk vs Reward
Poor
Good
Gavin Clark-Gartner's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Forte Biosciences IncFBRX | +285.14% | $19.99 | $76.99 | 2025-11-25 - 2026-08-27 | Buy |
Definium Therapeutics IncDFTX | +135.26% | $7.43 | $17.48 | 2025-01-28 - 2026-01-27 | Buy |
Argenx SeARGX | +76.16% | $354.13 | $623.82 | 2023-12-21 - 2024-12-20 | Buy |
Mirum Pharmaceuticals IncMIRM | +67.83% | $59.97 | $100.65 | 2025-08-08 - 2026-08-07 | Buy |
Argenx SeARGX | +53.92% | $596.74 | $918.50 | 2024-11-21 - 2025-11-20 | Buy |
Gavin Clark-Gartner Analyst Color
Get additional color on Gavin Clark-Gartner's coverage of popular stocks
Gavin Clark-Gartner's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Trex Bio IncTRXB | 1 | Buy | $28.00 | +104.83% | Initiates Coverage On | 11 days ago |
Argenx SeARGX | 8 | Buy | $1,090.00 | +13.54% | Maintains | 22 days ago |
First Tracks Biotherapeutics IncTRAX | 2 | Buy | $70.00 | +48.62% | Maintains | a month ago |
Mirum Pharmaceuticals IncMIRM | 7 | Buy | $146.00 | +55.34% | Maintains | a month ago |
Tenax Therapeutics IncTENX | 2 | Hold | $5.00 | +208.64% | Downgrades | 3 months ago |
Abbvie IncABBV | 9 | Buy | $260.00 | -11.87% | Maintains | 3 months ago |
Dianthus Therapeutics IncDNTH | 1 | Buy | $134.00 | +45.95% | Maintains | 3 months ago |
Compass Pathways PLCCMPS | 1 | Buy | $21.00 | +133.07% | Upgrades | 4 months ago |
Crinetics Pharmaceuticals IncCRNX | 1 | Hold | $85.00 | +0.06% | Downgrades | 4 months ago |
Proqr Therapeutics NvPRQR | 2 | Buy | $6.00 | +325.53% | Maintains | 5 months ago |
C4 Therapeutics IncCCCC | 2 | Buy | $12.00 | +334.78% | Maintains | 5 months ago |
Avalyn Pharma IncAVLN | 1 | Buy | $51.00 | +68.43% | Initiates Coverage On | 6 months ago |
Vera Therapeutics IncVERA | 2 | Buy | $91.00 | +223.84% | Maintains | 6 months ago |
Dyne Therapeutics IncDYN | 2 | Buy | $33.00 | +92.31% | Maintains | 6 months ago |
Krystal Biotech IncKRYS | 2 | Buy | $300.00 | -1.71% | Maintains | 6 months ago |
Meiragtx Holdings PLCMGTX | 1 | Buy | $18.00 | +96.08% | Maintains | 7 months ago |
Jasper Therapeutics IncJSPR | 5 | Buy | $210.00 | +1,435.09% | Maintains | 7 months ago |
Damora Therapeutics IncDMRA | 1 | Buy | $46.00 | +112.96% | Initiates Coverage On | 8 months ago |
Evommune IncEVMN | 1 | Buy | $40.00 | +424.25% | Initiates Coverage On | a year ago |
Forte Biosciences IncFBRX | 1 | Buy | $65.00 | -15.57% | Initiates Coverage On | a year ago |
Definium Therapeutics IncDFTX | 1 | Buy | $23.00 | N/A | Initiates Coverage On | 2 years ago |
Cabaletta Bio IncCABA | 2 | Hold | $6.00 | N/A | Downgrades | 2 years ago |
Sarepta Therapeutics IncSRPT | 9 | Buy | $170.00 | N/A | Maintains | 2 years ago |
Foghorn Therapeutics IncFHTX | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Aclaris Therapeutics IncACRS | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 3 years ago |
Inhibrx IncINBX1 | 1 | Buy | $60.00 | N/A | Maintains | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.